RBRussell R. C. Buchanan

Russell R. C. Buchanan

*This is an algorithmically generated author record based on publicly available information.

Russell R. C. Buchanan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes to physical function and body composition during the first 2 years of polymyalgia rheumatica

    by Jessica L Leung, Belinda De Ross, Jenny Gianoudis, Natalie Deeble, Victor Yang, David F L Liew, Robin M Daly, Russell R C Buchanan, Claire E Owen

    Objectives: To investigate physical function, body composition and frailty in recently diagnosed polymyalgia rheumatica (PMR) compared with controls. Methods: In a prospective cohort study, patients with PMR and age- and sex-matched controls were assessed 3 months after glucocorticoid initiation and 18 months later. Measures included the HAQ-DI, grip strength, gait speed, five times chair stand test, Short Physical Performance Battery (SPPB), maximum limb strength/power, habitual physical activity (by accelerometer) and body composition (by DEXA). Frailty was defined as per Fried’s phenotype. Results: Thirty-six participants with PMR and 32 controls were recruited. Participants with PMR had higher HAQ-DI scores (greater disability) than the controls at both visits (mean difference 0.33 [P < 0.001] and 0.39 [P < 0.001]). At follow-up, female participants with PMR performed more poorly in the chair stand test (mean difference 3.27 [95% CI: 0.69, 5.84], P = 0.02), SPPB (mean difference −1.23 [95% CI: −2.01, −0.45], P = 0.003) and gait speed (mean difference −0.24 [95% CI: −0.36, −0.12], P < 0.001) than the controls. Between timepoints, female participants with PMR had greater decline in gait speed than the controls (mean difference −0.13 [95% CI: −0.23, −0.03], P = 0.009). No significant differences for change in body composition were found. Pre-frailty rates were higher in participants with PMR than the controls (71.2% vs 34.4% (odds ratio 4.7 [P = 0.003]) and 60.7% vs 34.4% (odds ratio 2.9 [P = 0.04]) at the initial and follow-up visits, respectively). Conclusion: PMR has a lasting impact on physical function, particularly in females. These findings highlight the need for routine physical function assessments and targeted muscle conditioning measures in PMR management.


  • More Than Pain and Stiffness: Persistent Fatigue and Sleep Disturbance in Polymyalgia Rheumatica

    by Jessica L. Leung, Belinda De Ross, Jenny Gianoudis, Natalie Deeble, Victor Yang, Robert Azzopardi, David F.L. Liew, Robin M. Daly, Russell R.C. Buchanan, Claire E. Owen

    Objective: We aimed to examine fatigue and sleep disturbance in patients with recently diagnosed polymyalgia rheumatica (PMR) compared to age- and gender-matched controls, including associated characteristics and change over an 18-month follow-up period.Methods: Patients meeting the 2012 European Alliance of Associations for Rheumatology/American College of Rheumatology classification criteria for PMR were prospectively recruited, together with matched controls. Assessments were undertaken 3 months after the commencement of glucocorticoids and again 18 months later. Fatigue was quantified using the Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire and the 36-item Short Form Health Survey vitality scale. Sleep was quantified using the Pittsburgh Sleep Quality Index. Other data collected included PMR disease activity, depression, anxiety, and physical function status. All participants underwent body composition by dual-energy x-ray absorptiometry and physical function testing.Results: Thirty-six participants with PMR and 32 controls were included. PMR disease activity was low at both visits. Significantly, more patients with PMR than controls suffered severe fatigue (PMR: 36% and 35% at baseline and follow-up, respectively; controls: 3% at both timepoints). Poor sleep quality also affected more patients with PMR (77% and 84% at baseline and follow-up, respectively) than controls (56% at both timepoints). Higher BMI and fat mass index, anxiety, depression, PMR Activity Score, inflammatory markers, pain, and stiffness were all associated with severe fatigue. There were no significant associations with poor sleep.Conclusion: Patients with PMR experience a disproportionate degree of fatigue and sleep disturbance, which persists almost 2 years after starting treatment. Features associated with fatigue include higher adiposity, psychological comorbidity, and PMR disease activity.


  • Exploring the patient experience in polymyalgia rheumatica

    by Georgia K. Harris, Jessica L. Leung, Russell R. C. Buchanan

    Despite being the most common inflammatory rheumatic disease in the elderly (Partington et al., Ann Rheum Dis 77(12):1750-175, 2018), few studies to date have examined the patient experience of polymyalgia rheumatica (PMR). Our study explored patient perspectives in PMR by means of a survey and semi-structured group interviews. The results from this study highlight key aspects of the patient experience in PMR, including delays to diagnosis, complex attitudes toward glucocorticoid therapy, and a desire for alternate treatment strategies. Future trials should look to include physical function as a measured outcome. Finally, our results call attention to the chronicity of PMR symptoms, challenging the paradigm of PMR as a self-limiting condition.


  • Better diagnostic tools needed for biopsy-negative giant cell arteritis

    by Victor Yang, Christopher McMaster, Claire E Owen, Jessica L Y Leung, Bonnia Liu, Russell R C Buchanan, David F L Liew